| Petrelli F, Cabiddu M, Ghilardi M, et al.
Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based? [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Sep 8.
Abstract | Full Citation | Publisher Full Text |
| Cheng KL, Bradley T, Budman DR
Novel microtubule-targeting agents - the epothilones. [Journal Article]
Biologics 2008 Dec; 2(4):789-811.
Abstract | Full Citation |
| Puhalla S, Brufsky A
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer. [Journal Article]
Biologics 2008 Sep; 2(3):505-15.
Abstract | Full Citation |
| Schiff D, Wen PY, van den Bent MJ
Neurological adverse effects caused by cytotoxic and targeted therapies. [JOURNAL ARTICLE]
Nat Rev Clin Oncol 2009 Aug 25.
Abstract | Full Citation | Find Related Articles |
| Pivot XB, Li RK, Thomas ES, et al.
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer. [JOURNAL ARTICLE]
Eur J Cancer 2009 Aug 13.
Abstract | Full Citation |
| Rivera E
Management of Metastatic Breast Cancer: Monotherapy Options for Patients Resistant to Anthracyclines and Taxanes. [JOURNAL ARTICLE]
Am J Clin Oncol 2009 Aug 11.
Abstract | Full Citation |
| Nimeiri HS, Singh DA, Kasza K, et al.
The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium. [JOURNAL ARTICLE]
Invest New Drugs 2009 Aug 11.
Abstract | Full Citation | Find Related Articles |
| Moen MD
Ixabepilone: in locally advanced or metastatic breast cancer. [Journal Article]
Drugs 2009; 69(11):1471-81.
Abstract | Full Citation | Find Related Articles |
| Ho J, Zhang L, Todorova L, et al.
Budget impact analysis of ixabepilone used according to FDA approved labeling in treatment-resistant metastatic breast cancer. [Journal Article]
J Manag Care Pharm 2009 Jul-Aug; 15(6):467-75.
Abstract | Full Citation |
| Murphy CG, Seidman AD
Evolving Approaches to Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes. [JOURNAL ARTICLE]
Clin Breast Cancer 2009 Jun 1.:S58-S65.
Abstract | Full Citation | Find Related Articles |
   |
